Nobori Dual Antiplatelet Therapy as Appropriate Duration

PHASE4CompletedINTERVENTIONAL
Enrollment

3,773

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Coronary Artery Disease
Interventions
DRUG

Aspirin or thienopyridine

Subjects randomized 6 month DAPT will be prescribed either aspirin or thienopyridine (clopidogrel or ticlopidine) following 6 months DAPT for the duration of study, which is left on the physician's discretion.

DRUG

Aspirin and thienopyridine

Subjects randomized 18 month DAPT will be prescribed both aspirin and thienopyridine (clopidogrel or ticlopidine) for 18 month after stenting.

Trial Locations (1)

105-0013

Non-profit organization Associations for Establishment of Evidence in Interventions, Minato-ku

All Listed Sponsors
lead

Associations for Establishment of Evidence in Interventions

OTHER

NCT01514227 - Nobori Dual Antiplatelet Therapy as Appropriate Duration | Biotech Hunter | Biotech Hunter